Sharekhan

Fortis Healthcare Ltd

Tue 1/07/2025,14:24:59 | NSE : FORTIS

₹ 774.45-20.05 (-2.52%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 794.00

Previous Close

₹ 794.50

Volume

1308525

Mkt Cap ( Rs. Cr)

₹58467.73

High

₹ 794.00

Low

₹ 774.00

52 Week High

₹ 802.90

52 Week Low

₹ 453.00

Book Value Per Share

₹ 103.94

Dividend Yield

0.12

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Fortis Healthcare Ltd

Your Vote -

Buy

39.08%

Hold

59.15%

Sell

1.78%

39.08%

563 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

42%

Sell Order Quantity

58%

Bid Price

Qty

773.70

36

774.00

330

774.00

44

774.00

23

773.00

100

Bid Total

157318

Bid Price

Qty

773.75

49

774.00

483

774.00

416

774.00

217

774.00

419

Bid Total

220632

Option Chain

Analyzes market sentiment, predicts Fortis Healthcare Ltd' movement.

Call Price Open interest Strike Price Put Price Open interest

News

Media spotlight triggers stock stock attention, sentiment.

  • Fortis Healthcare - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    27 Jun 2025, 9:31PM FORTIS HEALTHCARE LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer A
  • Fortis Healthcare - General Updates

    27 Jun 2025, 9:28PM Fortis Healthcare Limited has informed the Exchange about General Updates
  • Fortis Healthcare - Resignation

    27 Jun 2025, 9:26PM Fortis Healthcare Limited has informed the Exchange regarding Resignation of Mr Mehmet Ali Aydinlar as Non- Executive Director of the company w.e.f. J
  • Fortis Healthcare - Change in Director(s)

    27 Jun 2025, 9:18PM Fortis Healthcare Limited has informed the Exchange regarding Change in Director(s) of the company.
  • Fortis Healthcare - Disclosure On Completion Of Term Of Independent Director

    27 Jun 2025, 9:05PM Relevant Dislcosure is attached
  • Fortis Healthcare - Announcement under Regulation 30 (LODR)-Resignation of Director

    27 Jun 2025, 9:00PM The Relevant Disclosure is attached
  • Fortis Healthcare - Announcement under Regulation 30 (LODR)-Resignation of Director

    27 Jun 2025, 8:50PM Pursuant to the provision of Regulation 30 of SEBI (LODR) Regulation, 2015, please find attached the relevant disclsoure for the resignation of Ms. Sh
  • Fortis Healthcare - Announcement under Regulation 30 (LODR)-Change in Directorate

    27 Jun 2025, 8:45PM Please find attached relevant disclsoure
  • Fortis Healthcare - Trading Window-XBRL

    27 Jun 2025, 2:48PM FORTIS HEALTHCARE LIMITED has informed the Exchange about Closure of Trading Window
  • Fortis Healthcare - Trading Window

    27 Jun 2025, 2:46PM Fortis Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations
  • Fortis Healthcare - Update-Acquisition/Scheme/Sale/Disposal-XBRL

    28 May 2025, 4:05PM FORTIS HEALTHCARE LIMITED has informed the Exchange regarding Update-Acquisition/Scheme/Sale/Disposal-XBRL
  • Fortis Healthcare - General Updates

    28 May 2025, 10:37AM In line with the announcement dated February 14, 2025 and March 21, 2025, Fortis Healthcare Limited has informed the Exchange about Updates on acquisi
  • Fortis Healthcare - Updates On Acquisition - Shrimann Hospital

    28 May 2025, 10:42AM The relevant disclosure is attached.
  • Fortis Healthcare - Announcement under Regulation 30 (LODR)-Updates on Acquisition

    28 May 2025, 10:35AM The relevant disclosure is attached.
  • Fortis Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    27 May 2025, 8:09PM Please find attached the Schedule of Investor Meet to be held on June 02 and 03, 2025.
  • Fortis Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    27 May 2025, 8:09PM Fortis Healthcare Limited has informed the Exchange about Schedule of meet to be held on June 2nd & 3rd, 2025 (Monday and Tuesday) at 09:30 AM onwards
  • Fortis Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    27 May 2025, 8:07PM Fortis Healthcare Limited has informed the Exchange about Schedule of meet to be held on June 2nd & 3rd, 2025 (Monday and Tuesday) at 09:30 AM onwards
  • Fortis Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    27 May 2025, 8:05PM Please find attached the Schedule of Investor Meet to be held on June 02 and 03, 2025.
  • Fortis Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    26 May 2025, 5:36PM Fortis Healthcare Limited has informed the Exchange about Transcript
  • Fortis Healthcare - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    26 May 2025, 5:24PM The relevant disclosure is attached
  • Fortis Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    21 May 2025, 4:31PM Fortis Healthcare Limited has informed the Exchange about Link of Recording
  • Fortis Healthcare - Copy of Newspaper Publication

    21 May 2025, 1:13PM Fortis Healthcare Limited has informed the Exchange about Copy of Newspaper Publication
  • Fortis Healthcare - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    21 May 2025, 12:01AM FORTIS HEALTHCARE LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer A
  • Fortis Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    21 May 2025, 4:33PM Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the investors / anal
  • Fortis Healthcare - Outcome of Board Meeting-XBRL

    20 May 2025, 11:53PM FORTIS HEALTHCARE LIMITED has informed the Exchange regarding Outcome of Board Meeting held on 20-May-2025 for Dividend
  • Fortis Healthcare - Statement of deviation(s) or variation(s) under Reg. 32

    20 May 2025, 11:42PM Fortis Healthcare Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
  • Fortis Healthcare - Updates

    20 May 2025, 11:11PM Fortis Healthcare Limited has informed the Exchange regarding material litigation filed by Northern TK Venture Pte Ltd., the Promoter shareholder of t
  • Fortis Healthcare - Disclosure Under Regulation 30 Of SEBI (Listing Obligations & \r\nDisclosure Requirements) Regulations 20

    20 May 2025, 11:01PM Relevant Disclosure is attached.
  • Fortis Healthcare - General Updates

    20 May 2025, 10:04PM Fortis Healthcare Limited has informed the Exchange about Compliance with respect to the Regulation 56(1)(d) of SEBI (Listing Obligations and Disclosu
  • Fortis Healthcare - Compliance With Respect To The Regulation 56(1)(D) Of SEBI (Listing Obligations And Disclosures Requireme

    20 May 2025, 10:00PM Relevant Disclosure with respect to Compliance with Covenants under Regulation 56(1)(d) is attached.
  • Fortis Healthcare - Press Release

    20 May 2025, 9:33PM Fortis Healthcare Limited has informed the Exchange regarding a press release dated May 20, 2025,
  • Fortis Healthcare - Investor Presentation

    20 May 2025, 9:29PM Fortis Healthcare Limited has informed the Exchange about Investor Presentation
  • Fortis Healthcare - Announcement under Regulation 30 (LODR)-Investor Presentation

    20 May 2025, 9:29PM Relevant Disclosure is attached.
  • Fortis Healthcare - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    20 May 2025, 9:27PM Relevant Disclosure is attached
  • Fortis Healthcare - Updates

    20 May 2025, 9:18PM Fortis Healthcare Limited has informed the Exchange regarding Compliance Pursuant to Regulation 54 & Regulation 56(1) (d) of SEBI (Listing Obligations
  • Fortis Healthcare - Compliances-Reg. 54 - Asset Cover details

    20 May 2025, 9:06PM Relevant Disclosure is attached.
  • Fortis Healthcare - Revision In Policies.

    20 May 2025, 8:20PM Relevant Disclosure is attached.
  • Fortis Healthcare - General Updates

    20 May 2025, 8:19PM Fortis Healthcare Limited has informed the Exchange about revision in Policy on Related Party Transactions and Policy for Prevention of Insider Tradin
  • Fortis Healthcare - Announcement under Regulation 30 (LODR)-Change in Management

    20 May 2025, 7:56PM Revised disclosure for Appointment of Secretarial and Cost Auditors is attached. Please note that there is no appointment/ change in Internal Auditors
  • Fortis Healthcare - General Updates

    20 May 2025, 7:36PM Fortis Healthcare Limited has informed the Exchange about Consideration and recommendation of final dividend of ₹1 per equity share for the fin
  • Fortis Healthcare - Appointment Of Secretarial Auditors And Cost Auditors.

    20 May 2025, 7:33PM Relevant Disclosure is attached.
  • Fortis Healthcare - General Updates

    20 May 2025, 7:30PM Fortis Healthcare Limited has informed the Exchange about Appointment of Secretarial Auditors for a term of Five (5) years and Appointment of Cost Aud
  • Fortis Healthcare - Corporate Action-Board approves Dividend

    20 May 2025, 7:29PM Relevant Disclosure is attached.
  • Fortis Healthcare - Change in Management

    20 May 2025, 7:26PM Fortis Healthcare Limited has informed the Exchange about Appointment of Cost Auditor for Financial Year 2025-26 and Appointment of Secretarial Audito
  • Fortis Healthcare - Announcement under Regulation 30 (LODR)-Dividend Updates

    20 May 2025, 7:25PM Relevant Disclosure with respect to declaration of Dividend by Board of Directors of the Company in their meeting held on May 20, 2025 is attached.
  • Fortis Healthcare - Dividend

    20 May 2025, 7:22PM Fortis Healthcare Limited has informed the Exchange that Board of Directors at its meeting held on May 20, 2025, recommended Final Dividend of Rs. 1.0
  • Fortis Healthcare - Announcement under Regulation 30 (LODR)-Change in Management

    20 May 2025, 7:22PM Relevant Disclosure with respect to Appointment of Secretarial and Internal Auditors is attached.
  • Fortis Healthcare - Outcome Of The Board Meeting Under Regulation 30, 33, 51(2) And Regulation 52 Of Securities And Exchange

    20 May 2025, 7:20PM The relevant disclosure is attached with respect to Audited Financial Results for the year ended March 31, 2025.
  • Fortis Healthcare - Outcome of Board Meeting

    20 May 2025, 7:18PM Fortis Healthcare Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.
  • Fortis Healthcare posts Q4 net loss of Rs 42.23 cr

    20 May 2025, 7:12PM The company reported standalone net loss during the quarter stood at Rs 42.23 crore compared to net profit of Rs 68.33 crore in the previous year quar
  • Fortis Healthcare - Board Meeting Outcome for Outcome Of The Board Meeting Under Regulation 30, 33, 51(2) And Regulation 52 O

    20 May 2025, 7:04PM Pursuant to the provisions of Regulation 30, 33 and Regulation 51(2) and 52 read with Schedule III of SEBI (Listing Obligations and Disclosures Requir
  • Fortis Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    16 May 2025, 8:21PM Fortis Healthcare Limited has informed the Exchange about Schedule of Investors' meet
  • Fortis Healthcare - Reschedule Of Investors/ Ananlysts' Call

    16 May 2025, 8:04PM The relevant disclosure with respect to reschedule of Investor/Ananlysts' Call is attached.
  • Fortis Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    16 May 2025, 7:58PM The relevant disclosure with respect to Re-Schedule of Investor/Analysts' Call is attached.
  • Fortis Healthcare - Reschedule Of Investors/ Ananlysts' Call

    16 May 2025, 8:04PM The relevant disclosure with respect to reschedule of Investor/Ananlysts' Call is attached.
  • Fortis Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    9 May 2025, 8:22PM Fortis Healthcare Limited has informed the Exchange about Schedule of meet
  • Fortis Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    9 May 2025, 8:18PM Please Find Attached Schedule of upcoming conference call invite to discuss the Company's audited financial results for the quarter and year ended Mar
  • Fortis Healthcare - Board Meeting Intimation

    9 May 2025, 6:56PM Fortis Healthcare Limited has informed the Exchange about Board Meeting to be held on 20-May-2025 to consider and approve the Yearly Audited Financial
  • Fortis Healthcare - Board Meeting Intimation for Notice Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations

    8 May 2025, 7:25PM Fortis Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2025 ,inter alia, to consider an
  • Fortis Healthcare - Updates

    5 May 2025, 8:57PM Fortis Healthcare Limited has informed the Exchange regarding 'Income Tax Rectification order for the material subsidiary Fortis Hospitals Limited'.
  • Fortis Healthcare - Disclosure Under Regulation 30 Of The SEBI (Listing Obligation & Disclosure Requirements) Regulations, 20

    5 May 2025, 8:37PM A detailed disclosure is attached
  • Fortis Healthcare - Updates

    30 Apr 2025, 1:28PM Fortis Healthcare Limited has informed the Exchange regarding 'Disclosure in terms of the SEBI Master Circular for issue and listing of Non-convertibl
  • Fortis Healthcare - Disclosure Under Chapter XIV - Centralized Database For Corporate Bonds/ Debentures Of SEBI Master Circul

    30 Apr 2025, 1:11PM Please find attached the disclosure pursuant to Chapter XIV - Centralized Database for Corporate Bonds/ Debenture in the prescribed format Annexure XI
  • Fortis Healthcare - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

    25 Apr 2025, 12:07PM <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border='1px'><tr> <td><b>Sr. No.</b></td
  • Fortis Healthcare has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    18 Apr 2025, 8:30PM As of March 2025, 31.17% is owned by Foreign Promoters and 68.83% by Public. <p align=justify> Institutional holds 56.86% (Insurance Companies 2.37%)
  • Fortis Healthcare - Disclosure under SEBI Takeover Regulations

    15 Apr 2025, 7:18PM Northern TK Venture Pte. Ltd. has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India
  • Fortis Healthcare - Updates

    10 Apr 2025, 10:50AM Fortis Healthcare Limited has informed the Exchange regarding 'Chapter VIII - Specifications related to ISIN for debt'.
  • Fortis Healthcare - Compliances-Half Yearly Report (SEBI Circular No. CIR/IMD/DF-1/67/2017)

    10 Apr 2025, 10:32AM Please find enclosed a Statement containing details of the Company's listed debt securities as per the format specified by SEBI as on March 31, 2025 f
  • Fortis Healthcare - General Updates

    3 Apr 2025, 5:49PM Fortis Healthcare Limited has informed the Exchange about Income Tax Order passed against the International Hospital Limited, an Indirect wholly owned
  • Fortis Healthcare - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    3 Apr 2025, 4:58PM Fortis Healthcare Limited has informed the Exchange about Certificate under regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018
  • Fortis Healthcare - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    3 Apr 2025, 4:51PM Please find enclosed certificate under Regulation 74(5) of SEBI (DP) regulations 2018.
  • Fortis Healthcare acquires 'Fortis' Trademark for Rs 200 cr via auction

    3 Apr 2025, 10:10AM Fortis Healthcare announced on Wednesday that it has successfully acquired the &lsquo;Fortis&rsquo; trademark through a public auction, securing the r
  • Fortis Healthcare - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order

    2 Apr 2025, 9:50PM The relevant disclosure with respect to Fortis Trademarks and Allied Trademarks is attached
  • Fortis Healthcare - Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

    2 Apr 2025, 9:46PM Fortis Healthcare Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
  • Fortis Healthcare - Updates

    2 Apr 2025, 9:42PM Fortis Healthcare Limited has informed the Exchange regarding 'Regarding Fortis Trademarks And Allied Trademarks'.
  • Fortis Healthcare - Disclosure Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) - Regarding Fortis

    2 Apr 2025, 9:02PM The relevant disclosure with respect to Fortis Trademarks and Allied Trademarks is attached.
  • Fortis Healthcare board approves acquiring Artistery Properties

    26 Sep 2023 , 10:18AM Fortis Healthcare to acquire 100% stake in Artistery Properties for Rs. 32 crore
  • Fortis Healthcare

    24 Jul 2023 , 12:17PM Fortis Healthcare Ltd.’s credit rating has been upgraded by CRISIL to CRISIL AA/Stable from CRISIL AA-/Positive due to sustained improvement in business risk profile of Fortis Healthcare Ltd. driven by steady occupancy, better surgical mix, and greater share of international patients leading to higher ARPOBs. Financial risk profile is also expected to stay comfortable over the medium term on the back of strong capital structure and debt protection metrics, despite growth plans. Positive for the stock
  • Fortis Healthcare to divest its business operations to Kauvery Group of Hospitals

    22 Jun 2023 , 4:28PM Fortis Healthcare enters business transfer agreement (BTA) with Sri Kauvery Medical Care for sale of business operations
  • Fortis Healthcare

    31 May 2021 , 9:54AM Fortis Healthcare: The company’s consolidated revenues grew by 12.5% to Rs1252.4crore as against revenues of Rs1112.9crore; Bed occupancy stood at 64% in Q4F21 (ARPOB at Rs1.7crore) as against 65% in Q4FY20. Operating profit grew by 57%yoy to Rs197.3crore as against Rs125.8crore. OPM stood at 15.8% in Q4FY21 vs. 11.3%. Interest cost was down by ~29% to Rs40.6crore. The company posted profit of Rs62.36crore as against loss pf Rs41.2crore
  • Fortis Healthcare

    22 Feb 2021 , 12:10PM The Supreme Court has asked 17 lenders to explain share sale by Fortis Healthcare's former promoter Malvindr Singh and Shivinder Singh. Lenders (including large financial institutions such as Axis Bank and HDFC Ltd) have been asked to specify value of encumbered and unencumbered shares held in 2017 as well as on subsequent dates. By February, 22 banks and financial institutions have to place record the loan advances given to the Singh brothers and Fortis Healthcare, nature of securities provided, along with details of share sold after 2017. The top court will now hear the case on February, 24 and will consider if a notice has to be issued to RHC Holdings
  • Stock in news: Fortis Healthcare

    14 Oct 2020 , 12:22PM Fortis Healthcare trade lower in poor market
  • Fortis Healthcare

    17 Jul 2020 , 11:32AM Supreme Court will give verdict on minority shareholder’s plea seeking to enforce IHH Healthcare Berhad’s takeover of Fortis Healthcare - if supreme court allows IHH Healthcare Berhad's to takeover stake in Fortis Healthcare it will help in further strengthening the balance sheet and removes key overhang on the stock
  • Fortis Healthcare

    6 Jul 2020 , 11:33AM The Supreme Court shall be hearing the plea on the open offer today. Any favourable outcome from the case would be positive
  • Fortis Healthcare in focus. Stock down

    15 Nov 2019 , 11:40AM Fortis Healthcare falls by 17% to Rs. 129, in strong market
  • Sebi directs Fortis firms to recover Rs. 403 cr from Singh brothers

    22 Mar 2019 , 11:09AM Fortis Healthcare: SEBI has asked both Fortis Healthcare and Fortis Hospitals to continue pursuing measures to recall the outstanding Rs 403 crore amount along with due interest from Singh Brothers and related entities – Stock to remain in focus.
  • Fortis Healthcare drops as SC puts share sale on hold

    14 Dec 2018 , 11:56AM Fortis Healthcare slips over 14% to Rs. 130.2, after Supreme Court puts sale of Fortis Healthcare on hold
  • Fortis board approves binding bid from Malaysia

    13 Jul 2018 , 9:47AM Fortis Healthcare board approves binding bid from Malaysia’s IHH Healthcare at Rs170/share
  • Fortis Healthcare board to consider fund raising

    11 Jul 2018 , 11:28AM Fortis Healthcare board to meet on July 13, to consider raising fund via issue of securities on a preferential allotment basis
  • Fortis board nod binding offer from Hero-Burman family

    11 May 2018 , 12:33PM Fortis Healthcare slips by 4% at Rs146.50, after board chooses the Hero Enterprises-Burman Family Office offer as the best for the hospital and diagnostic chain
  • Fortis board approves binding offer from Hero-Burman family offices

    11 May 2018 , 10:31AM Positive read through for Fortis Healthcare.
  • Fortis Healthcare approves evaluation of binding offers

    20 Apr 2018 , 10:14AM Stock to remain in focus
  • Manipal Hospital agrees to acquire Fortis Healthcare

    11 Apr 2018 , 10:07AM Positive read through for Fortis Healthcare.
  • Manipal & TPG combined to take control of Fortis

    27 Mar 2018 , 11:25AM Boards of Fortis and Manipal will meet today to discuss and finalize the deal. Stock to remain in focus
  • Yes Bank sells 2.17% stake in Fortis Healthcare

    16 Mar 2018 , 11:14AM Sentimentally negative for the stock (Sentimentally positive for Yes bank).
  • Fortis Healthcare gets notice from Serious Fraud Office

    5 Mar 2018 , 11:59AM Stock to remain in focus as Fortis Healthcare gets notice from Serious Fraud Office seeking information and documents.
  • Auditor's raise three red flags, promoters stake now at less than 1%

    1 Mar 2018 , 10:00AM Stock to remain in focus
  • Fortis Healthcare to announce Q2 and Q3 quarterly results

    28 Feb 2018 , 9:59AM Stock to remain in focus as auditor report will also be a key document.
  • Fortis

    23 Feb 2018 , 10:23AM Stock to remain in focus as Fortis Healthcare as all existing F&O contracts will expire on March 28, and no fresh contracts will be available if the firm fails to submit results for quarters ended September and December 2017 by March 1.
  • Fortis Healthcare promoter holdings comes down to 8.85%

    20 Feb 2018 , 12:42PM Stock to remain in focus as Fortis Healthcare promoter and promoter group holdings has come down to 8.85% from 34.43% following invocation of pledged shares.
  • Fortis drops after SC allows sell shares pledged by promoters

    16 Feb 2018 , 3:12PM Fortis Healthcare declines by 20% at Rs115, after supreme court allows the company's lenders to sell shares pledged by promoters
  • Supreme Court allows sale of Fortis Healthcare

    16 Feb 2018 , 10:56AM Negative for Fortis as stock could see selling pressure.
  • Fortis Healthcare stocks in a slump

    28 Dec 2017 , 9:17AM A negative read through for Fortis Healthcare stocks as Daiichi Sankyo intervenes against any potential stake sale in the hospital chain
  • SRL Diagnostic demerger from Fortis Healthcare deferred

    24 Aug 2017 , 8:52AM SRL Diagnostic demerger from Fortis Healthcare has been deferred yet again after the Supreme Court’s order directing promoters Malvinder and Shivinder Singh to maintain the status of shareholding of one of their companies’ in the hospital chain - sentimentally negative for Fortis Healthcare.
  • Fortis gains as RBI allow FII limit upto 74%

    10 Jul 2017 , 1:39PM Fortis Healthcare rises over 3% to Rs163.9, after RBI approves hike in foreign investment ceiling in the company upto 74% of the paid-up equity capita
  • Fortis plunges as IHH denies deal with health maker

    23 Jun 2017 , 12:33PM Fortis Healthcare slips by 12% to 174.45, after Malaysian hospital chain, IHH Healthcare Berhad (IHH), announces it was nowhere close to concluding a deal in healthcare services provider

Key fundamentals

Evaluate the intrinsic value of Fortis Healthcare Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 11112.53 9402.77 9333.32 9510.8958 9630.6699
Liabilities 11112.53 9402.77 9333.32 9510.8958 9630.6699
Equity 754.96 754.9581 754.9581 754.9581 754.9581
Gross Profit 255.51 192.8071 133.1458 115.4059 27.9095
Net Profit 63.79 199.4549 96.2401 -13.2506 4.1975
Cash From Operating Activities 334.02 218.4486 198.3775 76.4935 31.9435
NPM(%) 4.41 16.88 9.14 -1.53 0.66
Revenue 1445.89 1181.423 1052.926 862.6137 632.8735
Expenses 1190.38 988.6159 919.7802 747.2078 604.964
ROE(%) 0.81 2.54 1.22 -0.16 0.05

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
1 10 0.13 679.15
24 Jul 2024 1 10 0.13 468.95
20 Jul 2023 1 10 0.13 287.6

Peers

Other companies within the same industry or sector that are comparable to Fortis Healthcare Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 876.95 4.89 29.10 453.32 301.39 0.57
Lotus Eye Hospital and Institute Ltd 71.05 -0.15 203.00 1651.85 3.55 0.00
Vaishali Pharma Ltd 11.57 -0.26 192.83 851.43 3.13 0.00
Astec Lifesciences Ltd 945.80 2.29 0.00 1557.55 -687.10 0.00

Company Info

The registered office of the Company was initially situated at 25, Nehru Place, New Delhi 110 019, India. Pursuant to a Board resolution dated September 16, 2003 the registered office was shifted to B- 9, Maharani Bagh, New Delhi 110 065, India. Subsequently, pursuant to Board resolution dated February 10, 2006 the registered office of the Company was shifted to Piccadily House, 275- 276, 4th Floor, Captain Gaur Marg, Srinivas Puri, New Delhi 110 065, India, which is the current Registered Office. Scheme of merger/amalgamation between Fortis Medical Centre Holdings Limited and the Company dated October 7, 2005: The High Court of Delhi, through its order dated October 7, 2005 in respect of the company petition (C.P. No: 240/2005 and 241/2005) approved the scheme of amalgamation/merger between the Company and Fortis Medical Centre Holdings Limited ("FMCHL"), and which at the time of amalgamation was our board controlled subsidiary, with effect from April 1, 2004 ("Scheme"). Salient features of the Scheme: The principal terms of the Scheme, as sanctioned by the High Court of Delhi, are set forth below: The entire undertaking and business, all properties, tangible and intangible assets including trademarks, patents, design, copyrights, investments, approvals, licenses, tax benefits, pending projects, debts, liabilities and obligations, including income tax liabilities accrued or to accrue in FMCHL was transferred to the Company with effect from April 1, 2004. Pursuant to the Scheme, Fortis Hospital, Amritsar was transferred to the Company. However, the transfer of the aforesaid was subject to the existing charges or hypothecation in respect of the assets of FMCHL. All the staff, workmen and employees of FMCHL in employment on the date immediately preceding December 23, 2005 (i.e., the date on which a certified copy of the order of the High Court of Delhi was filed with the RoC) became the employees of the Company without any break or discontinuity in service and on conditions not less favourable than those subsisting at FMCHL. In consideration of the transfer and vesting of the undertaking and the assets and liabilities of FMCHL and in consideration of the mutual covenants agreed to in the Scheme, the Company agreed to allot the Equity Shares to the existing shareholders of FMCHL, in the ratio of 1:4 (i.e., one Equity Share in exchange of every four equity shares of FMCHL of Rs. 10 each). In compliance with the Scheme, the Company allotted 520,000 Equity Shares to the shareholders of erstwhile FMCHL on February 10, 2006. Major Events: Year Event June 2001 Commissioning of Fortis Hospital, Mohali. August 2003 Inauguration and commissioning of Fortis Hospital, Amritsar. October 2003 Executed an agreement with Seth Jessa Ram and Bros Charitable Hospital Trust for the operation and management of Jessa Ram Hospital, New Delhi. August 200 Commissioning of Fortis Hospital, Noida. September 2005 Acquired 90% of the equity share capital of Escorts Heart Institute and Research Centre Limited resulting in the acquisition of EHCL, EHSSIL, EHSSHL and EHRCL. October 2005 Signed an agreement with Jeewan Mala Hospital Private Limited for the operation and maintenance of Jeewan Mala Hospital, New Delhi. January 2006 Signed an agreement with Sunrise Medicare Private Limited for the operation and management of Fortis La Femme, New Delhi, and acquisition of 5% equity interest in Sunrise Medicare Private Limited, with an option to acquire additional equity shares. January 2006 Signed an agreement with Khalil Public Welfare Trust for the operation and maintenance of Khyber Medical Institute, Srinagar. March 2006 Acquired 99.99% of the paid up equity share capital of International Hospital Limited resulting in the acquisition of Fortis Hospital, Noida. March 2006 Acquired 100.00% of the paid up equity share capital of Oscar Bio-Tech Private Limited. 2004 -Fortis inks deal with Jessa Ram Hospital to takeover the management of the hospital 2005 -Fortis Hospital rolls out Golden Age Club -Fortis buys Escorts Heart -Fortis Healthcare signs $33.33m pre-IPO deals The Company was incorporated on February 28, 1996 as Rancare Limited under the Companies Act. Subsequently on June 20, 1996 our name was changed to our present name-Fortis Healthcare Limited. The Company received the certificate of commencement of business on July 1, 1996. 2006 -Fortis Healthcare to buy majority stake in Trehan`s Medicity -Fortis Healthcare signs $33.33m pre-IPO deals 2007 -Fortis HealthWorld has joined hands with US hearing aid maker Starkey for its Audible range and is looking to soon offer dental services at its Health stores too. -Colgate-Palmolive India, the market leader in toothpaste in India, declared the acquisition of three domestic companies in south India recently. The company purchased 75 per cent equity in Advanced Oral Care Products (Goa), Professional Oral Care Products (Goa) and SS Oral Hygiene Products (Hyderabad). -Fortis Healthcare acquires Hiranandani Hospital 2008 -Fortis Healthcare Ltd has informed that the Board of Directors of the Company at its meeting held on January 23, 2008, inter alia, has approved change in registered office of the Company from "Piccadily House, 275-276, 4th Floor, Captain Gaur Marg, Srinivas Puri, New Delhi - 110065" to "Escorts Health Institute And Research Centre, Okhla Road, New Delhi - 110025". 2009 -Fortis completes Wockhardt Hospital Acquisition -Fortis signs $15 mn outsourcing deal with HCL -Fortis Healthcare Ltd Issues Rights in the Ratio of 2:5 2010 - 25% stake in Parkway holdings, Asia's largest private healthcare provider. - "Fortis Healthcare infuses USD 100 Million". - Fortis increases stake in Parkway. - Government of Singapore Investment Corp (GIC) to join hands with Fortis at strategic level. - Fortis Healthcare has entered into a pact with two hospitals in Dubai and Tanzania to set up specialised medical facilities. - Company has announced its foray into Speciality Medical Centres focused on the management of diabetes, metabolic diseases and endocrinology. 2011 - A Memorandum of Understanding has been signed by Fortis Healthcare Ltd with the University of Utah to develop courses for Emergency Medical Technicians. - Through its wholly owned subsidiary, has entered into an agreement with Cauvery Hospital Limited, Mysore, wherein Fortis will set up, operate and manage a Cardiac Centre in the hospital. - The name of Fortis Healthcare Limited shall be changed to Fortis Healthcare (India) Limited w.e.f. April 11, 2011. - "Fortis Healthcare ties up with TotipotentRX to set up Stem Cell Therapy Centres". - Fortis Healthcare (India) Ltd has announced that it will buy 86 per cent stake in Super Religare Laboratories Ltd (SRL) . - Fortis Healt - Fortis announces new hospitals in Hyderabad and Agra. 2012 - "Fortis to get Rs. 3700 Mn Equity infusion in SRL through IFC and NYLIM Jacob Ballas India". - Fortis Healthcare raises around S$510 mn through Singapore IPO. -Company has changed its name from Fortis Healthcare (India) Ltd. to Fortis Healthcare Ltd. 2013 -"Fortis launches its Flagship Hospital, One of the First of its Kind in Asia Bridges the gap for expert talent, trans-disciplinary, quaternary care". -"Fortis to divest stake in Quality Healthcare to Bupa for US$ 355 million Intensifies Focus on Healthcare Delivery in India". 2014 -"Fortis launches state of the art, multi super-specialty hospital in Ludhiana". 2016 -Fortis Healthcare has fully acquired Religare Health Trust Trustee Manager for USD 14.9 million (about Rs 100 crore). -Fortis group gets CCI nod for internal reorganisation. -Fortis Healthcare First in India to Monitor and Publish Clinical Outcomes for Cardiology. -Fortis Healthcare launches National helpline for students and parents to help deal exam stress. 2017 -Fortis Healthcare Acquisition of Hiranandani Healthcare Private Limited,Fortis Healthcare Holdings Private Limited and RHC Holding Private Limited. 2018 - Fortis Healthcare receives non-binding offer from Fosun - Fortis Healthcare takeover saga - Fortis Healthcare extends deadline for submission of binding bids 2019 - Fortis Healthcare launches UnmuteYourself challenge in partnership with TikTok - Fortis Healthcare contributes Rs One crore to the Chief Minister's Relief Fund, Assam - Fortis join hands with Tips for Music4MentalHealth Initiative - Fortis Healthcare - Trading Plan under PIT 2020 - Fortis rolls out e-Consultations for remote patient care in 23 hospitals across multiple locations in India -Fortis Healthcare contributes INR 5.90 crore to the PM National Relief Fund for COVID-19 relief works -Fortis announces its intent to rebrand as `Parkway', a leading IHH brand 2021 -More than 1500 women administered COVID19 vaccine for free at Fortis Hospitals on Women's Day. 2022 -Fortis Hospital Jaipur performs successful SWAP living donor kidney transplant, saves lives of two. -Fortis Hospital Gurugram partners with Children's Hospital Los Angeles (USA) for enhanced paediatric liver transpl Fortis Memorial Research Institute, Gurgaon. -Fortis Gurugram successfully treats 29-year-old women with Scleroderma - a rare form of arthritis via autologous stem cell transplant. 2023 -Fortis Escorts Jaipur organizes `ACE SEPSIS SYMPOSIA 2023' to discuss Critical Care approaches related to Sepsis Care. -Fortis Hospital Nagarbhavi launches State-of-the-Art AZURION 7C12 Cath Lab. -Fortis Bannerghatta Road Successfully Completes 500 Robotic Aided Urology Procedures via Da Vinci Xi. -Fortis Healthcare Launches 85-Bedded Multi-Speciality Hospital at Richmond Road, Bengaluru. 2024 -Fortis Ludhiana Successfully Treats 70-Year-Old ManÿforÿMassive Stroke Within the Golden Hour. -Fortis Mohali offers advanced `Mechanical Thrombectomy' treatment for brain stroke patients -Fortis Hospital, Anandpur Kolkata conducts Basic Life Support (BLS) Training session at Gokhale Memorial Girls' College (GMGC) -Fortis Escorts, Okhla Road, New Delhi Launches Next Generation Surgical Robot.

The registered office of the Company was initially situated at 25, Nehru Place, New Delhi 110 019, India. Pursuant to a Board resolution dated September 16, 2003 the registered office was shifted to B- 9, Maharani Bagh, New Delhi 110 065, India. Subsequently, pursuant to Board resolution dated February 10, 2006 the registered office of the Company was shifted to Piccadily House, 275- 276, 4th Floor, Captain Gaur Marg, Srinivas Puri, New Delhi 110 065, India, which is the current Registered Office. Scheme of merger/amalgamation between Fortis Medical Centre Holdings Limited and the Company dated October 7, 2005: The High Court of Delhi, through its order dated October 7, 2005 in respect of the company petition (C.P. No: 240/2005 and 241/2005) approved the scheme of amalgamation/merger between the Company and Fortis Medical Centre Holdings Limited ("FMCHL"), and which at the time of amalgamation was our board controlled subsidiary, with effect from April 1, 2004 ("Scheme"). Salient features of the Scheme: The principal terms of the Scheme, as sanctioned by the High Court of Delhi, are set forth below: The entire undertaking and business, all properties, tangible and intangible assets including trademarks, patents, design, copyrights, investments, approvals, licenses, tax benefits, pending projects, debts, liabilities and obligations, including income tax liabilities accrued or to accrue in FMCHL was transferred to the Company with effect from April 1, 2004. Pursuant to the Scheme, Fortis Hospital, Amritsar was transferred to the Company. However, the transfer of the aforesaid was subject to the existing charges or hypothecation in respect of the assets of FMCHL. All the staff, workmen and employees of FMCHL in employment on the date immediately preceding December 23, 2005 (i.e., the date on which a certified copy of the order of the High Court of Delhi was filed with the RoC) became the employees of the Company without any break or discontinuity in service and on conditions not less favourable than those subsisting at FMCHL. In consideration of the transfer and vesting of the undertaking and the assets and liabilities of FMCHL and in consideration of the mutual covenants agreed to in the Scheme, the Company agreed to allot the Equity Shares to the existing shareholders of FMCHL, in the ratio of 1:4 (i.e., one Equity Share in exchange of every four equity shares of FMCHL of Rs. 10 each). In compliance with the Scheme, the Company allotted 520,000 Equity Shares to the shareholders of erstwhile FMCHL on February 10, 2006. Major Events: Year Event June 2001 Commissioning of Fortis Hospital, Mohali. August 2003 Inauguration and commissioning of Fortis Hospital, Amritsar. October 2003 Executed an agreement with Seth Jessa Ram and Bros Charitable Hospital Trust for the operation and management of Jessa Ram Hospital, New Delhi. August 200 Commissioning of Fortis Hospital, Noida. September 2005 Acquired 90% of the equity share capital of Escorts Heart Institute and Research Centre Limited resulting in the acquisition of EHCL, EHSSIL, EHSSHL and EHRCL. October 2005 Signed an agreement with Jeewan Mala Hospital Private Limited for the operation and maintenance of Jeewan Mala Hospital, New Delhi. January 2006 Signed an agreement with Sunrise Medicare Private Limited for the operation and management of Fortis La Femme, New Delhi, and acquisition of 5% equity interest in Sunrise Medicare Private Limited, with an option to acquire additional equity shares. January 2006 Signed an agreement with Khalil Public Welfare Trust for the operation and maintenance of Khyber Medical Institute, Srinagar. March 2006 Acquired 99.99% of the paid up equity share capital of International Hospital Limited resulting in the acquisition of Fortis Hospital, Noida. March 2006 Acquired 100.00% of the paid up equity share capital of Oscar Bio-Tech Private Limited. 2004 -Fortis inks deal with Jessa Ram Hospital to takeover the management of the hospital 2005 -Fortis Hospital rolls out Golden Age Club -Fortis buys Escorts Heart -Fortis Healthcare signs $33.33m pre-IPO deals The Company was incorporated on February 28, 1996 as Rancare Limited under the Companies Act. Subsequently on June 20, 1996 our name was changed to our present name-Fortis Healthcare Limited. The Company received the certificate of commencement of business on July 1, 1996. 2006 -Fortis Healthcare to buy majority stake in Trehan`s Medicity -Fortis Healthcare signs $33.33m pre-IPO deals 2007 -Fortis HealthWorld has joined hands with US hearing aid maker Starkey for its Audible range and is looking to soon offer dental services at its Health stores too. -Colgate-Palmolive India, the market leader in toothpaste in India, declared the acquisition of three domestic companies in south India recently. The company purchased 75 per cent equity in Advanced Oral Care Products (Goa), Professional Oral Care Products (Goa) and SS Oral Hygiene Products (Hyderabad). -Fortis Healthcare acquires Hiranandani Hospital 2008 -Fortis Healthcare Ltd has informed that the Board of Directors of the Company at its meeting held on January 23, 2008, inter alia, has approved change in registered office of the Company from "Piccadily House, 275-276, 4th Floor, Captain Gaur Marg, Srinivas Puri, New Delhi - 110065" to "Escorts Health Institute And Research Centre, Okhla Road, New Delhi - 110025". 2009 -Fortis completes Wockhardt Hospital Acquisition -Fortis signs $15 mn outsourcing deal with HCL -Fortis Healthcare Ltd Issues Rights in the Ratio of 2:5 2010 - 25% stake in Parkway holdings, Asia's largest private healthcare provider. - "Fortis Healthcare infuses USD 100 Million". - Fortis increases stake in Parkway. - Government of Singapore Investment Corp (GIC) to join hands with Fortis at strategic level. - Fortis Healthcare has entered into a pact with two hospitals in Dubai and Tanzania to set up specialised medical facilities. - Company has announced its foray into Speciality Medical Centres focused on the management of diabetes, metabolic diseases and endocrinology. 2011 - A Memorandum of Understanding has been signed by Fortis Healthcare Ltd with the University of Utah to develop courses for Emergency Medical Technicians. - Through its wholly owned subsidiary, has entered into an agreement with Cauvery Hospital Limited, Mysore, wherein Fortis will set up, operate and manage a Cardiac Centre in the hospital. - The name of Fortis Healthcare Limited shall be changed to Fortis Healthcare (India) Limited w.e.f. April 11, 2011. - "Fortis Healthcare ties up with TotipotentRX to set up Stem Cell Therapy Centres". - Fortis Healthcare (India) Ltd has announced that it will buy 86 per cent stake in Super Religare Laboratories Ltd (SRL) . - Fortis Healt - Fortis announces new hospitals in Hyderabad and Agra. 2012 - "Fortis to get Rs. 3700 Mn Equity infusion in SRL through IFC and NYLIM Jacob Ballas India". - Fortis Healthcare raises around S$510 mn through Singapore IPO. -Company has changed its name from Fortis Healthcare (India) Ltd. to Fortis Healthcare Ltd. 2013 -"Fortis launches its Flagship Hospital, One of the First of its Kind in Asia Bridges the gap for expert talent, trans-disciplinary, quaternary care". -"Fortis to divest stake in Quality Healthcare to Bupa for US$ 355 million Intensifies Focus on Healthcare Delivery in India". 2014 -"Fortis launches state of the art, multi super-specialty hospital in Ludhiana". 2016 -Fortis Healthcare has fully acquired Religare Health Trust Trustee Manager for USD 14.9 million (about Rs 100 crore). -Fortis group gets CCI nod for internal reorganisation. -Fortis Healthcare First in India to Monitor and Publish Clinical Outcomes for Cardiology. -Fortis Healthcare launches National helpline for students and parents to help deal exam stress. 2017 -Fortis Healthcare Acquisition of Hiranandani Healthcare Private Limited,Fortis Healthcare Holdings Private Limited and RHC Holding Private Limited. 2018 - Fortis Healthcare receives non-binding offer from Fosun - Fortis Healthcare takeover saga - Fortis Healthcare extends deadline for submission of binding bids 2019 - Fortis Healthcare launches UnmuteYourself challenge in partnership with TikTok - Fortis Healthcare contributes Rs One crore to the Chief Minister's Relief Fund, Assam - Fortis join hands with Tips for Music4MentalHealth Initiative - Fortis Healthcare - Trading Plan under PIT 2020 - Fortis rolls out e-Consultations for remote patient care in 23 hospitals across multiple locations in India -Fortis Healthcare contributes INR 5.90 crore to the PM National Relief Fund for COVID-19 relief works -Fortis announces its intent to rebrand as `Parkway', a leading IHH brand 2021 -More than 1500 women administered COVID19 vaccine for free at Fortis Hospitals on Women's Day. 2022 -Fortis Hospital Jaipur performs successful SWAP living donor kidney transplant, saves lives of two. -Fortis Hospital Gurugram partners with Children's Hospital Los Angeles (USA) for enhanced paediatric liver transpl Fortis Memorial Research Institute, Gurgaon. -Fortis Gurugram successfully treats 29-year-old women with Scleroderma - a rare form of arthritis via autologous stem cell transplant. 2023 -Fortis Escorts Jaipur organizes `ACE SEPSIS SYMPOSIA 2023' to discuss Critical Care approaches related to Sepsis Care. -Fortis Hospital Nagarbhavi launches State-of-the-Art AZURION 7C12 Cath Lab. -Fortis Bannerghatta Road Successfully Completes 500 Robotic Aided Urology Procedures via Da Vinci Xi. -Fortis Healthcare Launches 85-Bedded Multi-Speciality Hospital at Richmond Road, Bengaluru. 2024 -Fortis Ludhiana Successfully Treats 70-Year-Old ManÿforÿMassive Stroke Within the Golden Hour. -Fortis Mohali offers advanced `Mechanical Thrombectomy' treatment for brain stroke patients -Fortis Hospital, Anandpur Kolkata conducts Basic Life Support (BLS) Training session at Gokhale Memorial Girls' College (GMGC) -Fortis Escorts, Okhla Road, New Delhi Launches Next Generation Surgical Robot.

Read More

Parent Organisation

Fortis Healthcare Ltd.

Founded

28/02/1996

Managing Director

Dr.Ashutosh Raghuvanshi

NSE Symbol

FORTISEQ

FAQ

The current price of Fortis Healthcare Ltd is ₹ 774.45.

The 52-week high for Fortis Healthcare Ltd is ₹ 794.00 and the 52-week low is ₹ 774.00.

The market capitalization of Fortis Healthcare Ltd is currently ₹ 58467.73. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Fortis Healthcare Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Fortis Healthcare Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Fortis Healthcare Ltd shares.

The CEO of Fortis Healthcare Ltd is Dr.Ashutosh Raghuvanshi, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT